Latest News
Marinomed Biotech AG (VSE:MARI), an Austrian science-based biotech company with globally marketed therapeutics derived from innovative proprietary technology platforms, has secured EUR5.4 million in financing via a flexible Convertible Notes Funding Programme (CNFP) from the Swiss investment firm Nice & Green.
The flexible financing provided by this programme enables Marinomed to advance its scientific and clinical programs for its two proprietary assets, the virus blocking Carragelose technology and the Marinosolv platform for the solubilisation of pharmaceutical compounds.
Under the terms of the agreement, Marinomed Biotech AG is entitled to issue up to 18 tranches of zero-coupon convertible bonds of up
MIG Capital AG has sold portfolio company, Hemovent to MicroPort Surgical BV, a subsidiary of Shanghai-based MicroPort Scientific Corporation, (MicroPort) for a total purchase price of up to EUR123 million.
Split between two funds MIG holds more than 27 per cent of Hemovent.
Hemovent develops and manufactures Extra Corporal Lung Support (ECLS) systems for the intensive care setting. Based on the classic heart-lung machine, this technology takes over the heart and/or lung function of a patient for up to several weeks. Hemovent wants to significantly expand the application range of these life-saving systems, particularly for emergency use. The proprietary MOBYBOX
Mammoth Scientific, a health science and technology venture capital firm, has selected SS&C as administrator and technology partner for its inaugural USD100 million fund.
The fund will provide venture capital to health science and technology companies maturing beyond seed rounds.
The venture capital firm is building a proprietary platform to enable registered investment advisors to access venture capital investments for their retail clients. As a result, they needed a partner to provide proven independent fund administration for their new funds plus technology to support their retail client strategy. After evaluating multiple vendors, Mammoth Scientific chose SS&C’s private markets solution,
Therapeutics AG (iOmx), a biopharmaceutical company developing cancer therapeutics based on next generation immune checkpoint targets, has closed a Series B round totalling EUR65 million.
The financing was co-led by Athos Service GmbH – the Strüngmann family office – and MIG Capital AG, with participation from existing investors Wellington Partners, Sofinnova Partners and M Ventures.
The new funds will be invested to advance the company’s lead program IMT-07, a SIK3 kinase inhibitor to treat solid tumours, through the first-in-man clinical trial, and to further develop IMT-18, a first-in-class IGSF11-targeting antibody to treat PD-1/PD-L1-resistant tumors. In addition, iOmx will continue to
Eatable Adventures has launched its first fund – the EUR50 million Eatable Evolution Fund FCR I. The vehicle will make early and growth-stage investments targeting the most disruptive startups in food and agriculture tech across Europe and Latin America.
This will be the biggest fund of its kind in Spain and one of the top three in Europe.
This milestone marks a new stage of growth for the company, that has already launched more than 10 accelerator and incubation programs, while collaborating as the go-to advisor on open innovation for the leading global food corporations.
The fund’s launch arrives as
techspert.io, an AI technology specialist connecting businesses with experts for domain-specific industry insights, has closed a USD12 million investment round led by BGF.
The volume of online data, information and misinformation is growing exponentially, as is the speed with which markets and products evolve. It is therefore increasingly challenging and important for businesses to cut through all the noise and get the rapid insights they need for smart decision making.
Based in Cambridge, UK, techspert.io maps and predicts expertise across over 200 million experts worldwide, using a knowledge graph covering millions of expertise areas. This enables businesses to access
An affiliate of HIG Capital (HIG) has sold Quicken Inc (Quicken) to Aquiline Capital Partners (Aquiline).
Quicken is a leading provider of personal financial management (PF) software and services. Its personal finance software and apps allow users to track and categorise bank and card transactions, pay bills, track and manage investments, budget, and plan for retirement, among other things. The Quicken product line includes solutions that cater to different financial needs and user preferences across systems (Mac and Windows) and devices (desktop, mobile, and web), giving consumers flexible access to their finances. After a successful carve-out transaction from Intuit, Inc,
Graycliff Partners has completed an equity investment and recapitalisation of CHawk Technology International (CHawk), a manufacturer of precision plastic and metal components and assemblies for the semiconductor capital equipment, aerospace, and medical device industries.
Based in Hayward, CA and founded in 2005, CHawk provides plastic and metal machining, fabrication, clean room assembly, and engineering services. The company’s core market is semiconductor capital equipment, with a growing presence in aerospace, medical, and general industrial end markets. The company has facilities in California, Arizona, Singapore, Malaysia, and China. Graycliff’s investment in CHawk follows its July 2021 acquisition of Gold Tech Industries, a
DIF Capital Partners (DIF) through its DIF Infrastructure VI fund, is to acquire Bernhard, a privately-owned Energy-as-a-Service (EaaS) solutions company in the United States, from an affiliate of Bernhard Capital Partners.
Bernhard has provided solutions to its customers’ energy and infrastructure needs for more than 100 years and shifted its focus in 2014 to becoming a leading Energy-as-a-Service provider. As part of this business model, Bernhard enters into long-term turnkey EaaS concession contracts to upgrade, retrofit and service large existing building energy facilities in order to achieve substantial energy savings. Clients are currently predominantly higher education and healthcare institutions. To
Carlyle has appointed Ryan Selwood, former Head of Direct Private Equity at Canada Pension Plan Investment Board (CPP Investments), as Managing Director and Chief Development Officer.
In this newly created position, Selwood will be involved in a range of investment and management activities across Carlyle, working alongside many in leadership to drive major priorities including growth initiatives and corporate M&A. He also will serve on Investment Committees across all segments of the firm, including our Corporate Capital Commitments Committee. Ryan will join Carlyle on 1 January, 2022, reporting to CEO Kewsong Lee.
“We are thrilled to welcome Ryan to the
Special Reports
Featured
- Insight
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
